AZTA
Price
$23.31
Change
+$0.64 (+2.82%)
Updated
Jun 18 closing price
Capitalization
1.07B
51 days until earnings call
Intraday BUY SELL Signals
CRL
Price
$185.00
Change
+$2.66 (+1.46%)
Updated
Jun 18 closing price
Capitalization
8.91B
52 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AZTA vs CRL

AZTA vs CRL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AZTA vs. CRL commentary
Jun 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a Hold and CRL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 21, 2026
Stock price -- (AZTA: $23.31 vs. CRL: $185.00)
Brand notoriety: AZTA and CRL are both not notable
AZTA represents the Pharmaceuticals: Other, while CRL is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AZTA: 97% vs. CRL: 136%
Market capitalization -- AZTA: $1.07B vs. CRL: $8.91B
AZTA [@Pharmaceuticals: Other] is valued at $1.07B. CRL’s [@Medical Specialties] market capitalization is $8.91B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $144.07B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $7.6B. The average market capitalization across the [@Medical Specialties] industry is $15.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileCRL’s FA Score has 1 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • CRL’s FA Score: 1 green, 4 red.
According to our system of comparison, both AZTA and CRL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 5 TA indicator(s) are bullish while CRL’s TA Score has 6 bullish TA indicator(s).

  • AZTA’s TA Score: 5 bullish, 5 bearish.
  • CRL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CRL is a better buy in the short-term than AZTA.

Price Growth

AZTA (@Pharmaceuticals: Other) experienced а +3.78% price change this week, while CRL (@Medical Specialties) price change was -1.63% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.06%. For the same industry, the average monthly price growth was +5.15%, and the average quarterly price growth was -12.66%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.17%. For the same industry, the average monthly price growth was +8.92%, and the average quarterly price growth was -2.29%.

Reported Earning Dates

AZTA is expected to report earnings on Aug 11, 2026.

CRL is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+3.06% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (-1.17% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRL($8.91B) has a higher market cap than AZTA($1.07B). CRL has higher P/E ratio than AZTA: CRL (577.05) vs AZTA (42.43). CRL YTD gains are higher at: -7.259 vs. AZTA (-29.916). CRL has higher annual earnings (EBITDA): 291M vs. AZTA (36.6M). AZTA has more cash in the bank: 381M vs. CRL (192M). AZTA has less debt than CRL: AZTA (55.7M) vs CRL (3.06B). CRL has higher revenues than AZTA: CRL (4.03B) vs AZTA (596M).
AZTACRLAZTA / CRL
Capitalization1.07B8.91B12%
EBITDA36.6M291M13%
Gain YTD-29.916-7.259412%
P/E Ratio42.43577.057%
Revenue596M4.03B15%
Total Cash381M192M198%
Total Debt55.7M3.06B2%
FUNDAMENTALS RATINGS
AZTA vs CRL: Fundamental Ratings
AZTA
CRL
OUTLOOK RATING
1..100
4790
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
88
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9594
PRICE GROWTH RATING
1..100
4843
P/E GROWTH RATING
1..100
861
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZTA's Valuation (50) in the Electronic Production Equipment industry is somewhat better than the same rating for CRL (88) in the Miscellaneous Commercial Services industry. This means that AZTA’s stock grew somewhat faster than CRL’s over the last 12 months.

AZTA's Profit vs Risk Rating (100) in the Electronic Production Equipment industry is in the same range as CRL (100) in the Miscellaneous Commercial Services industry. This means that AZTA’s stock grew similarly to CRL’s over the last 12 months.

CRL's SMR Rating (94) in the Miscellaneous Commercial Services industry is in the same range as AZTA (95) in the Electronic Production Equipment industry. This means that CRL’s stock grew similarly to AZTA’s over the last 12 months.

CRL's Price Growth Rating (43) in the Miscellaneous Commercial Services industry is in the same range as AZTA (48) in the Electronic Production Equipment industry. This means that CRL’s stock grew similarly to AZTA’s over the last 12 months.

CRL's P/E Growth Rating (1) in the Miscellaneous Commercial Services industry is significantly better than the same rating for AZTA (86) in the Electronic Production Equipment industry. This means that CRL’s stock grew significantly faster than AZTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTACRL
RSI
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
66%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
82%
Momentum
ODDS (%)
Bullish Trend 4 days ago
72%
Bearish Trend 4 days ago
76%
MACD
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
70%
Bearish Trend 4 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
65%
Advances
ODDS (%)
Bullish Trend 6 days ago
70%
Bullish Trend 13 days ago
69%
Declines
ODDS (%)
Bearish Trend 17 days ago
82%
Bearish Trend 5 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
71%
Bearish Trend 4 days ago
75%
Aroon
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
AZTA
Daily Signal:
Gain/Loss:
CRL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QUIK21.901.04
+4.99%
QuickLogic Corp
KBSX1.200.01
+0.84%
FST Corp
TVACU10.60N/A
N/A
Texas Ventures Acquisition III Corp
ORI38.69-0.04
-0.10%
Old Republic International Corp
NTST19.20-0.25
-1.29%
NetSTREIT Corp

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with IQV. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
+2.80%
IQV - AZTA
60%
Loosely correlated
-1.70%
RVTY - AZTA
59%
Loosely correlated
+2.23%
A - AZTA
59%
Loosely correlated
+2.20%
MTD - AZTA
59%
Loosely correlated
+1.36%
BRKR - AZTA
58%
Loosely correlated
+4.57%
More

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been closely correlated with IQV. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRL jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
+1.46%
IQV - CRL
75%
Closely correlated
-1.70%
TMO - CRL
69%
Closely correlated
+0.63%
RVTY - CRL
64%
Loosely correlated
+2.23%
A - CRL
62%
Loosely correlated
+2.20%
DHR - CRL
60%
Loosely correlated
-0.33%
More